The NASDAQ 100 Pre-Market Indicator is up 266.97 points to 24,647.7, with total pre-market volume at 131,572,296 shares. CytomX Therapeutics (CTMX) is the most active pre-market name, trading 27,793,236 shares and rising $2.34 to $7.02, indicating concentrated pre-market liquidity in a single biotech name but no market-moving news for the broader market.
The NASDAQ 100 Pre-Market Indicator is up 266.97 points to 24,647.7, with total pre-market volume at 131,572,296 shares. CytomX Therapeutics (CTMX) is the most active pre-market name, trading 27,793,236 shares and rising $2.34 to $7.02, indicating concentrated pre-market liquidity in a single biotech name but no market-moving news for the broader market.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
